In case 3 from our cohort, the observation of an EGFR mutation in both the biopsy and resection specimens of the same tumor, but the presence of IDH1 mutation only in the biopsy specimen also supports that the IDH1 mutation was a branching driver occurring during the subclonal evolution in lung adenocarcinoma. This evidence concerns the gene EGFR and neoplasm.